Literature DB >> 8989116

C-type natriuretic peptide in human coronary atherosclerotic lesions.

T Naruko1, M Ueda, A C van der Wal, C M van der Loos, H Itoh, K Nakao, A E Becker.   

Abstract

BACKGROUND: C-type natriuretic peptide (CNP) belongs to the natriuretic peptide family and is considered to have regulatory effects on vascular tone and smooth muscle growth. Since these features play a role in atherogenesis, the presence of CNP at such sites was studied. METHODS AND
RESULTS: Thirty-three coronary artery segments were harvested at autopsy: 10 normal, with diffuse intimal thickening, and 23 atherosclerotic lesions. Samples were snap-frozen and processed for immunohistochemical staining. For the identification of CNP, a mouse monoclonal antibody (KY-CNP-1) was used. 1A4, EBM-11 (CD68), and von Willebrand factor antibodies were used to stain smooth muscle cells, macrophages, and endothelial cells, respectively. CNP is present in several cell types. Normal arterial segments show CNP-positive endothelial cells. Hypercellular atherosclerotic lesions show distinct CNP positivity of smooth muscle cells and macrophages but a decrease in positivity of endothelial cells. Advanced atherosclerotic lesions contain CNP-positive macrophages, but the smooth muscle cells within the fibrous cap and the surface endothelial cells are almost all CNP-negative.
CONCLUSIONS: These observations suggest that CNP has functional significance in atherogenesis.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8989116     DOI: 10.1161/01.cir.94.12.3103

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  11 in total

1.  Multiple immunoenzyme staining: methods and visualizations for the observation with spectral imaging.

Authors:  Chris M van der Loos
Journal:  J Histochem Cytochem       Date:  2007-12-23       Impact factor: 2.479

Review 2.  Natriuretic peptides in cardiometabolic regulation and disease.

Authors:  Nora E Zois; Emil D Bartels; Ingrid Hunter; Birgitte S Kousholt; Lisbeth H Olsen; Jens P Goetze
Journal:  Nat Rev Cardiol       Date:  2014-05-13       Impact factor: 32.419

3.  Significance and therapeutic potential of the natriuretic peptides/cGMP/cGMP-dependent protein kinase pathway in vascular regeneration.

Authors:  Kenichi Yamahara; Hiroshi Itoh; Tae-Hwa Chun; Yoshihiro Ogawa; Jun Yamashita; Naoki Sawada; Yasutomo Fukunaga; Masakatsu Sone; Takami Yurugi-Kobayashi; Kazutoshi Miyashita; Hirokazu Tsujimoto; Hyun Kook; Robert Feil; David L Garbers; Franz Hofmann; Kazuwa Nakao
Journal:  Proc Natl Acad Sci U S A       Date:  2003-03-05       Impact factor: 11.205

4.  Endothelial C-Type Natriuretic Peptide Is a Critical Regulator of Angiogenesis and Vascular Remodeling.

Authors:  Kristen J Bubb; Aisah A Aubdool; Amie J Moyes; Sarah Lewis; Jonathan P Drayton; Owen Tang; Vedanta Mehta; Ian C Zachary; David J Abraham; Janice Tsui; Adrian J Hobbs
Journal:  Circulation       Date:  2019-03-26       Impact factor: 29.690

5.  Circulating C-type natriuretic peptide and its relationship to cardiovascular disease in the general population.

Authors:  S Jeson Sangaralingham; Paul M McKie; Tomoko Ichiki; Christopher G Scott; Denise M Heublein; Horng H Chen; Kent R Bailey; Margaret M Redfield; Richard J Rodeheffer; John C Burnett
Journal:  Hypertension       Date:  2015-04-20       Impact factor: 10.190

6.  C-type natriuretic peptide inhibits leukocyte recruitment and platelet-leukocyte interactions via suppression of P-selectin expression.

Authors:  Ramona S Scotland; Marc Cohen; Paul Foster; Matthew Lovell; Anthony Mathur; Amrita Ahluwalia; Adrian J Hobbs
Journal:  Proc Natl Acad Sci U S A       Date:  2005-09-22       Impact factor: 11.205

7.  Molecular imaging of atherosclerotic plaque with (64)Cu-labeled natriuretic peptide and PET.

Authors:  Yongjian Liu; Dana Abendschein; Geoffrey E Woodard; Raffaella Rossin; Kyle McCommis; Jie Zheng; Michael J Welch; Pamela K Woodard
Journal:  J Nucl Med       Date:  2009-12-15       Impact factor: 10.057

Review 8.  C-type natriuretic peptide (CNP): cardiovascular roles and potential as a therapeutic target.

Authors:  Natalie G Lumsden; Rayomand S Khambata; Adrian J Hobbs
Journal:  Curr Pharm Des       Date:  2010       Impact factor: 3.116

9.  Natriuretic peptide receptor-3 underpins the disparate regulation of endothelial and vascular smooth muscle cell proliferation by C-type natriuretic peptide.

Authors:  Rayomand S Khambata; Catherine M Panayiotou; Adrian J Hobbs
Journal:  Br J Pharmacol       Date:  2011-09       Impact factor: 8.739

10.  Natriuretic peptides: Diagnostic and therapeutic use.

Authors:  Kaushik Pandit; Pradip Mukhopadhyay; Sujoy Ghosh; Subhankar Chowdhury
Journal:  Indian J Endocrinol Metab       Date:  2011-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.